Jonathan Alspaugh
2022
In 2022, Jonathan Alspaugh earned a total compensation of $1M as Chief Financial Officer at Aeglea BioTherapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $130,560 |
|---|---|
| Option Awards | $443,285 |
| Salary | $425,001 |
| Other | $12,994 |
| Total | $1,011,840 |
Alspaugh received $443.3K in option awards, accounting for 44% of the total pay in 2022.
Alspaugh also received $130.6K in non-equity incentive plan, $425K in salary and $13K in other compensation.
Rankings
In 2022, Jonathan Alspaugh's compensation ranked 2,961st out of 5,542 executives tracked by ExecPay. In other words, Alspaugh earned more than 46.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,961 out of 5,542 | 47th |
Division Manufacturing | 1,653 out of 3,000 | 45th |
Major group Chemicals And Allied Products | 769 out of 1,350 | 43rd |
Industry group Drugs | 716 out of 1,253 | 43rd |
Industry Pharmaceutical Preparations | 515 out of 907 | 43rd |
Source: SEC filing on October 26, 2023.
Alspaugh's colleagues
We found four more compensation records of executives who worked with Jonathan Alspaugh at Aeglea BioTherapeutics in 2022.